Repligen | RGEN - 销售收入

金融业

USD 180.01

USD 2.95B

现金及等价物

USD 606.78M

USD 94.09M

USD 1.2B

USD 132.66M

USD 690.94M

USD 21.13M

USD 43.77M

1.78K

EPS每股收益

USD 0.54

股本和储备

USD 2.11B

USD 110.04M

债务利息支出

USD 5.66M

USD 7.31M

USD 551.05M

USD 10.1B

USD 5.01M

USD 183M

USD 21.13M

普通股股本

USD 56.43M

105.09

USD 14.15M

USD 204M

销售和管理费用

USD 76.62M

USD 186.6M

贸易债权人

USD 33.23M

应收帐款人

USD 157.71M

	销售	更改		日
Agilent	USD 1.88B		43M	2026-06
Align Technology	USD 1.06B		20M	2026-06
Bio Techne	USD 321.2M		9.8M	2026-06
BioMarin Pharmaceutical	USD 990M		224M	2026-06
Bristol-Myers Squibb	USD 12.97B		1.48B	2026-06
Bruker	USD 838.5M		15.1M	2026-06
Charles River Laboratories	USD 1000M		4.2M	2026-06
Danaher	USD 6.55B		254M	2026-09
Dentsply International	USD 898M		18M	2026-06
General Electric Aerospace	USD 14.12B		1.49B	2026-09
Henry Schein	USD 3.46B		90M	2026-06
Illumina	USD 1.16B		70M	2026-06
IQVIA Holdings	USD 4.37B		220M	2026-06
Mettler Toledo International	USD 1.03B		82.87M	2026-06
Myriad Genetics	USD 190.7M		9.7M	2026-06
OraSure Technologies	USD 26.76M		322K	2025-12
Pacific Biosciences Of California	USD 44.64M		6.2M	2025-12
Pfizer	USD 15.03B		530M	2026-06
Repligen	USD 204M		10M	2026-06
Revvity	USD 729.68M		18.68M	2026-06
Standard Biotools	USD 21.1M		2.7M	2026-03
Thermo Fisher Scientific	USD 12.14B		147M	2026-09
Waters	USD 1.64B		370M	2026-06
West Pharmaceutical Services	USD 872.3M		27.4M	2026-06